πŸ‡ΊπŸ‡Έ FDA
Patent

US 10557850

Anti-CXCR1 compositions and methods

granted A61KA61K31/18A61K31/337

Quick answer

US patent 10557850 (Anti-CXCR1 compositions and methods) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/18, A61K31/337, A61K45/06, A61P